Business
Press Release Jun 17 2024
Alembic Pharmaceuticals Limited has informed the Exchange regarding a press release dated Jun 17, 2024, titled "Alembic Pharmaceuticals receives USFDA Final Approval for Icatibant Injection, 30 mg/3 mL (10 mg/mL) Single-Dose Prefilled Syringe.".
About this update from Alembic Pharmaceuticals Limited
[{"type":"text","content":" Alembic Pharmaceuticals Limited has informed the Exchange regarding a press release dated Jun 17, 2024, titled \"Alembic Pharmaceuticals receives USFDA Final Approval for Icatibant Injection, 30 mg/3 mL (10 mg/mL) Single-Dose Prefilled Syringe.\". View Attachment","length":430,"tagName":"div"}]